M
Mohammad Ali Nilforoushzadeh
Researcher at Tehran University of Medical Sciences
Publications - 182
Citations - 2287
Mohammad Ali Nilforoushzadeh is an academic researcher from Tehran University of Medical Sciences. The author has contributed to research in topics: Medicine & Cutaneous leishmaniasis. The author has an hindex of 19, co-authored 152 publications receiving 1594 citations. Previous affiliations of Mohammad Ali Nilforoushzadeh include University of Tehran & Isfahan University of Medical Sciences.
Papers
More filters
Journal ArticleDOI
Can regenerative medicine and nanotechnology combine to heal wounds? The search for the ideal wound dressing.
Payam Zarrintaj,Abolfazl Salehi Moghaddam,Saeed Manouchehri,Zhaleh Atoufi,Anahita Amiri,Mohammad Amir Amirkhani,Mohammad Ali Nilforoushzadeh,Mohammad Reza Saeb,Michael R. Hamblin,Masoud Mozafari +9 more
TL;DR: Antimicrobial activity, exogenous cell therapy, growth factor delivery, biodegradable and biocompatible matrix construction, all play a role in hi-tech dressing design.
Journal ArticleDOI
Impact of the COVID-19 pandemic on the sexual behavior of the population. The vision of the east and the west.
François Peinado Ibarra,Mehri Mehrad,Marina Di Mauro,Maria Fernanda Peraza Godoy,Eduard García Cruz,Mohammad Ali Nilforoushzadeh,Giorgio Ivan Russo +6 more
TL;DR: The impact of the coronavirus will be very important in the sexual life of the people and will attend in the next months or years, to some changes in the relationships at all the levels.
Journal ArticleDOI
Skin care and rejuvenation by cosmeceutical facial mask.
Mohammad Ali Nilforoushzadeh,Mohammad Amir Amirkhani,Payam Zarrintaj,Abolfazl Salehi Moghaddam,Tina Mehrabi,Shiva Alavi,Mahsa Mollapour Sisakht +6 more
TL;DR: This review presents the most recent breakthroughs in the field of skin care and rejuvenation by cosmeceutical facial mask to get the picture of the latest trends and also helpful for clinicians and related manufacturing companies.
Journal ArticleDOI
A randomized, double-blind, placebo-controlled clinical trial of itraconazole in the treatment of cutaneous leishmaniasis.
Mansour Nassiri-Kashani,Alireza Firooz,Ali Khamesipour,F Mojtahed,Mohammad Ali Nilforoushzadeh,H. Hejazi,Navid Bouzari,Y Dowlati +7 more
TL;DR: This work has shown inhibitory effects of azole drugs on Leishmania parasites on cutaneous leishmaniasis through in vitro and in vivo studies.
Journal ArticleDOI
Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis.
TL;DR: First line treatment for cutaneous leishmaniasis is antimonial compounds; however, owing to the intermittent failure of this treatment and its significant side‐effects alternative therapeutic measures have been advocated.